Clinical Trial Update: Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating whether CK+/CD45+ double-positive circulating cells are of tumor origin in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Metastatic Breast Cancer | NA | Status: COMPLETED